Click for best price
Prostate Cancer Treatment Market Size, Share 2024
| Market size in 2023 |
US$ 16270 million
|
Forecast Market size by 2030 |
US$ 24390 million
|
| Growth Rate |
CAGR of 5.9% |
Number of Pages |
104 Pages |
The global Prostate Cancer Treatment market was valued at US$ 16270 million in 2023 and is projected to reach US$ 24390 million by 2030, at a CAGR of 5.9% during the forecast period.
The USA market for Global Prostate Cancer Treatment market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Prostate Cancer Treatment market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Prostate Cancer Treatment market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
This research report provides a comprehensive analysis of the Prostate Cancer Treatment market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Prostate Cancer Treatment market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Prostate Cancer Treatment, challenges faced by the industry, and potential opportunities for market players.
The global Prostate Cancer Treatment market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Prostate Cancer Treatment market presents opportunities for various stakeholders, including Hospital, Research Institution. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Prostate Cancer Treatment market. Additionally, the growing consumer demand present avenues for market expansion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022.
The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Prostate Cancer Treatment market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Prostate Cancer Treatment market.
Market Overview: The report provides a comprehensive overview of the Prostate Cancer Treatment market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Biological Therapy, Chemotherapy), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Prostate Cancer Treatment market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Prostate Cancer Treatment market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Prostate Cancer Treatment market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Prostate Cancer Treatment market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Prostate Cancer Treatment market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Prostate Cancer Treatment market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Prostate Cancer Treatment, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Prostate Cancer Treatment market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
- Prostate Cancer Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Biological Therapy
- Chemotherapy
Market segment by Application
- Hospital
- Research Institution
- Clinic
Global Prostate Cancer Treatment Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Major players covered
- Tolmar
- Astellas Pharma
- AstraZeneca
- Ferring Pharmaceuticals
- Johnson & Johnson
- Abbott
- Sanofi
- Ipsen
- Novartis
- Bayer
Outline of Major Chapters:
Chapter 1: Introduces the definition of Prostate Cancer Treatment, market overview.
Chapter 2: Global Prostate Cancer Treatment market size in revenue.
Chapter 3: Detailed analysis of Prostate Cancer Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prostate Cancer Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Prostate Cancer Treatment Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 16270 million
|
| Forecast Market size by 2030 |
US$ 24390 million
|
| Growth Rate |
CAGR of 5.9% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
104 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Prostate Cancer Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prostate Cancer Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prostate Cancer Treatment Overall Market Size
2.1 Global Prostate Cancer Treatment Market Size: 2023 VS 2030
2.2 Global Prostate Cancer Treatment Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Prostate Cancer Treatment Players in Global Market
3.2 Top Global Prostate Cancer Treatment Companies Ranked by Revenue
3.3 Global Prostate Cancer Treatment Revenue by Companies
3.4 Top 3 and Top 5 Prostate Cancer Treatment Companies in Global Market, by Revenue in 2023
3.5 Global Companies Prostate Cancer Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prostate Cancer Treatment Players in Global Market
3.6.1 List of Global Tier 1 Prostate Cancer Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Prostate Cancer Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Prostate Cancer Treatment Market Size Markets, 2023 & 2030
4.1.2 Biological Therapy
4.1.3 Chemotherapy
4.2 By Type - Global Prostate Cancer Treatment Revenue & Forecasts
4.2.1 By Type - Global Prostate Cancer Treatment Revenue, 2019-2024
4.2.2 By Type - Global Prostate Cancer Treatment Revenue, 2025-2030
4.2.3 By Type - Global Prostate Cancer Treatment Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Prostate Cancer Treatment Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Research Institution
5.1.4 Clinic
5.2 By Application - Global Prostate Cancer Treatment Revenue & Forecasts
5.2.1 By Application - Global Prostate Cancer Treatment Revenue, 2019-2024
5.2.2 By Application - Global Prostate Cancer Treatment Revenue, 2025-2030
5.2.3 By Application - Global Prostate Cancer Treatment Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Prostate Cancer Treatment Market Size, 2023 & 2030
6.2 By Region - Global Prostate Cancer Treatment Revenue & Forecasts
6.2.1 By Region - Global Prostate Cancer Treatment Revenue, 2019-2024
6.2.2 By Region - Global Prostate Cancer Treatment Revenue, 2025-2030
6.2.3 By Region - Global Prostate Cancer Treatment Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Prostate Cancer Treatment Revenue, 2019-2030
6.3.2 US Prostate Cancer Treatment Market Size, 2019-2030
6.3.3 Canada Prostate Cancer Treatment Market Size, 2019-2030
6.3.4 Mexico Prostate Cancer Treatment Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Prostate Cancer Treatment Revenue, 2019-2030
6.4.2 Germany Prostate Cancer Treatment Market Size, 2019-2030
6.4.3 France Prostate Cancer Treatment Market Size, 2019-2030
6.4.4 U.K. Prostate Cancer Treatment Market Size, 2019-2030
6.4.5 Italy Prostate Cancer Treatment Market Size, 2019-2030
6.4.6 Russia Prostate Cancer Treatment Market Size, 2019-2030
6.4.7 Nordic Countries Prostate Cancer Treatment Market Size, 2019-2030
6.4.8 Benelux Prostate Cancer Treatment Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Prostate Cancer Treatment Revenue, 2019-2030
6.5.2 China Prostate Cancer Treatment Market Size, 2019-2030
6.5.3 Japan Prostate Cancer Treatment Market Size, 2019-2030
6.5.4 South Korea Prostate Cancer Treatment Market Size, 2019-2030
6.5.5 Southeast Asia Prostate Cancer Treatment Market Size, 2019-2030
6.5.6 India Prostate Cancer Treatment Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Prostate Cancer Treatment Revenue, 2019-2030
6.6.2 Brazil Prostate Cancer Treatment Market Size, 2019-2030
6.6.3 Argentina Prostate Cancer Treatment Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Prostate Cancer Treatment Revenue, 2019-2030
6.7.2 Turkey Prostate Cancer Treatment Market Size, 2019-2030
6.7.3 Israel Prostate Cancer Treatment Market Size, 2019-2030
6.7.4 Saudi Arabia Prostate Cancer Treatment Market Size, 2019-2030
6.7.5 UAE Prostate Cancer Treatment Market Size, 2019-2030
7 Prostate Cancer Treatment Companies Profiles
7.1 Tolmar
7.1.1 Tolmar Company Summary
7.1.2 Tolmar Business Overview
7.1.3 Tolmar Prostate Cancer Treatment Major Product Offerings
7.1.4 Tolmar Prostate Cancer Treatment Revenue in Global Market (2019-2024)
7.1.5 Tolmar Key News & Latest Developments
7.2 Astellas Pharma
7.2.1 Astellas Pharma Company Summary
7.2.2 Astellas Pharma Business Overview
7.2.3 Astellas Pharma Prostate Cancer Treatment Major Product Offerings
7.2.4 Astellas Pharma Prostate Cancer Treatment Revenue in Global Market (2019-2024)
7.2.5 Astellas Pharma Key News & Latest Developments
7.3 AstraZeneca
7.3.1 AstraZeneca Company Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Prostate Cancer Treatment Major Product Offerings
7.3.4 AstraZeneca Prostate Cancer Treatment Revenue in Global Market (2019-2024)
7.3.5 AstraZeneca Key News & Latest Developments
7.4 Ferring Pharmaceuticals
7.4.1 Ferring Pharmaceuticals Company Summary
7.4.2 Ferring Pharmaceuticals Business Overview
7.4.3 Ferring Pharmaceuticals Prostate Cancer Treatment Major Product Offerings
7.4.4 Ferring Pharmaceuticals Prostate Cancer Treatment Revenue in Global Market (2019-2024)
7.4.5 Ferring Pharmaceuticals Key News & Latest Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Prostate Cancer Treatment Major Product Offerings
7.5.4 Johnson & Johnson Prostate Cancer Treatment Revenue in Global Market (2019-2024)
7.5.5 Johnson & Johnson Key News & Latest Developments
7.6 Abbott
7.6.1 Abbott Company Summary
7.6.2 Abbott Business Overview
7.6.3 Abbott Prostate Cancer Treatment Major Product Offerings
7.6.4 Abbott Prostate Cancer Treatment Revenue in Global Market (2019-2024)
7.6.5 Abbott Key News & Latest Developments
7.7 Sanofi
7.7.1 Sanofi Company Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Prostate Cancer Treatment Major Product Offerings
7.7.4 Sanofi Prostate Cancer Treatment Revenue in Global Market (2019-2024)
7.7.5 Sanofi Key News & Latest Developments
7.8 Ipsen
7.8.1 Ipsen Company Summary
7.8.2 Ipsen Business Overview
7.8.3 Ipsen Prostate Cancer Treatment Major Product Offerings
7.8.4 Ipsen Prostate Cancer Treatment Revenue in Global Market (2019-2024)
7.8.5 Ipsen Key News & Latest Developments
7.9 Novartis
7.9.1 Novartis Company Summary
7.9.2 Novartis Business Overview
7.9.3 Novartis Prostate Cancer Treatment Major Product Offerings
7.9.4 Novartis Prostate Cancer Treatment Revenue in Global Market (2019-2024)
7.9.5 Novartis Key News & Latest Developments
7.10 Bayer
7.10.1 Bayer Company Summary
7.10.2 Bayer Business Overview
7.10.3 Bayer Prostate Cancer Treatment Major Product Offerings
7.10.4 Bayer Prostate Cancer Treatment Revenue in Global Market (2019-2024)
7.10.5 Bayer Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Prostate Cancer Treatment Market Opportunities & Trends in Global Market
Table 2. Prostate Cancer Treatment Market Drivers in Global Market
Table 3. Prostate Cancer Treatment Market Restraints in Global Market
Table 4. Key Players of Prostate Cancer Treatment in Global Market
Table 5. Top Prostate Cancer Treatment Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Prostate Cancer Treatment Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Prostate Cancer Treatment Revenue Share by Companies, 2019-2024
Table 8. Global Companies Prostate Cancer Treatment Product Type
Table 9. List of Global Tier 1 Prostate Cancer Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prostate Cancer Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Prostate Cancer Treatment Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Prostate Cancer Treatment Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Prostate Cancer Treatment Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Prostate Cancer Treatment Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Prostate Cancer Treatment Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Prostate Cancer Treatment Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Prostate Cancer Treatment Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Prostate Cancer Treatment Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Prostate Cancer Treatment Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Prostate Cancer Treatment Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Prostate Cancer Treatment Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Prostate Cancer Treatment Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Prostate Cancer Treatment Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Prostate Cancer Treatment Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Prostate Cancer Treatment Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Prostate Cancer Treatment Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Prostate Cancer Treatment Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Prostate Cancer Treatment Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Prostate Cancer Treatment Revenue, (US$, Mn), 2025-2030
Table 30. Tolmar Company Summary
Table 31. Tolmar Prostate Cancer Treatment Product Offerings
Table 32. Tolmar Prostate Cancer Treatment Revenue (US$, Mn) & (2019-2024)
Table 33. Tolmar Key News & Latest Developments
Table 34. Astellas Pharma Company Summary
Table 35. Astellas Pharma Prostate Cancer Treatment Product Offerings
Table 36. Astellas Pharma Prostate Cancer Treatment Revenue (US$, Mn) & (2019-2024)
Table 37. Astellas Pharma Key News & Latest Developments
Table 38. AstraZeneca Company Summary
Table 39. AstraZeneca Prostate Cancer Treatment Product Offerings
Table 40. AstraZeneca Prostate Cancer Treatment Revenue (US$, Mn) & (2019-2024)
Table 41. AstraZeneca Key News & Latest Developments
Table 42. Ferring Pharmaceuticals Company Summary
Table 43. Ferring Pharmaceuticals Prostate Cancer Treatment Product Offerings
Table 44. Ferring Pharmaceuticals Prostate Cancer Treatment Revenue (US$, Mn) & (2019-2024)
Table 45. Ferring Pharmaceuticals Key News & Latest Developments
Table 46. Johnson & Johnson Company Summary
Table 47. Johnson & Johnson Prostate Cancer Treatment Product Offerings
Table 48. Johnson & Johnson Prostate Cancer Treatment Revenue (US$, Mn) & (2019-2024)
Table 49. Johnson & Johnson Key News & Latest Developments
Table 50. Abbott Company Summary
Table 51. Abbott Prostate Cancer Treatment Product Offerings
Table 52. Abbott Prostate Cancer Treatment Revenue (US$, Mn) & (2019-2024)
Table 53. Abbott Key News & Latest Developments
Table 54. Sanofi Company Summary
Table 55. Sanofi Prostate Cancer Treatment Product Offerings
Table 56. Sanofi Prostate Cancer Treatment Revenue (US$, Mn) & (2019-2024)
Table 57. Sanofi Key News & Latest Developments
Table 58. Ipsen Company Summary
Table 59. Ipsen Prostate Cancer Treatment Product Offerings
Table 60. Ipsen Prostate Cancer Treatment Revenue (US$, Mn) & (2019-2024)
Table 61. Ipsen Key News & Latest Developments
Table 62. Novartis Company Summary
Table 63. Novartis Prostate Cancer Treatment Product Offerings
Table 64. Novartis Prostate Cancer Treatment Revenue (US$, Mn) & (2019-2024)
Table 65. Novartis Key News & Latest Developments
Table 66. Bayer Company Summary
Table 67. Bayer Prostate Cancer Treatment Product Offerings
Table 68. Bayer Prostate Cancer Treatment Revenue (US$, Mn) & (2019-2024)
Table 69. Bayer Key News & Latest Developments
List of Figures
Figure 1. Prostate Cancer Treatment Segment by Type in 2023
Figure 2. Prostate Cancer Treatment Segment by Application in 2023
Figure 3. Global Prostate Cancer Treatment Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Prostate Cancer Treatment Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Prostate Cancer Treatment Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Prostate Cancer Treatment Revenue in 2023
Figure 8. By Type - Global Prostate Cancer Treatment Revenue Market Share, 2019-2030
Figure 9. By Application - Global Prostate Cancer Treatment Revenue Market Share, 2019-2030
Figure 10. By Type - Global Prostate Cancer Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Prostate Cancer Treatment Revenue Market Share, 2019-2030
Figure 12. By Application - Global Prostate Cancer Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Prostate Cancer Treatment Revenue Market Share, 2019-2030
Figure 14. By Region - Global Prostate Cancer Treatment Revenue Market Share, 2019-2030
Figure 15. By Country - North America Prostate Cancer Treatment Revenue Market Share, 2019-2030
Figure 16. US Prostate Cancer Treatment Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Prostate Cancer Treatment Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Prostate Cancer Treatment Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Prostate Cancer Treatment Revenue Market Share, 2019-2030
Figure 20. Germany Prostate Cancer Treatment Revenue, (US$, Mn), 2019-2030
Figure 21. France Prostate Cancer Treatment Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Prostate Cancer Treatment Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Prostate Cancer Treatment Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Prostate Cancer Treatment Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Prostate Cancer Treatment Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Prostate Cancer Treatment Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Prostate Cancer Treatment Revenue Market Share, 2019-2030
Figure 28. China Prostate Cancer Treatment Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Prostate Cancer Treatment Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Prostate Cancer Treatment Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Prostate Cancer Treatment Revenue, (US$, Mn), 2019-2030
Figure 32. India Prostate Cancer Treatment Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Prostate Cancer Treatment Revenue Market Share, 2019-2030
Figure 34. Brazil Prostate Cancer Treatment Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Prostate Cancer Treatment Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Prostate Cancer Treatment Revenue Market Share, 2019-2030
Figure 37. Turkey Prostate Cancer Treatment Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Prostate Cancer Treatment Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Prostate Cancer Treatment Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Prostate Cancer Treatment Revenue, (US$, Mn), 2019-2030
Figure 41. Tolmar Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Astellas Pharma Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. AstraZeneca Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Ferring Pharmaceuticals Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Johnson & Johnson Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Abbott Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Sanofi Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Ipsen Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Novartis Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Bayer Prostate Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
